• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚性瘢痕的形成:演变与易感性

Formation of hypertrophic scars: evolution and susceptibility.

作者信息

Mahdavian Delavary Babak, van der Veer Willem M, Ferreira José A, Niessen Frank B

机构信息

Department of Plastic, Reconstructive and Hand Surgery, VU University Medical Center, Van der Boechorststraat 7, Amsterdam, The Netherlands.

出版信息

J Plast Surg Hand Surg. 2012 Apr;46(2):95-101. doi: 10.3109/2000656X.2012.669184.

DOI:10.3109/2000656X.2012.669184
PMID:22471257
Abstract

Formation of hypertrophic scars is a common complication of wound healing, and at present little is known about the incidence and risk factors. Our aim was to analyse the incidence, progression, and regression of postoperative hypertrophic scars over time and to identify risk factors of hypertrophic scars. Patients who had had bilateral reduction mammoplasty or median sternotomy incision were included in the study. All patients were examined at 3 and 12 months postoperatively. We recorded: height, weight, allergy status, smoking status, skin type, tanning, and shape of the scar 3 and 12 months postoperatively. Of the 204 patients who were included, 122 (60%) developed a hypertrophic scar within 12 months of operation. Of these patients, 117 (96%) developed a hypertrophic scar within 3 months of operation. Twelve months postoperatively, 66/204 patients (32%) had a hypertrophic scar. In 31 of the 66 of the patients with a hypertrophic scar 3 months postoperatively (47%), the hypertrophic scar(s) regressed after 3 and 12 months. Smoking and age were associated with formation of hypertrophic scars. In conclusion, 60% of patients developed hypertrophic scars postoperatively, typically during the first three months. Most hypertrophic scars that are present after three months are still hypertrophic after 12 months. Young, non-smoking patients are more susceptible to formation of hypertrophic scars.

摘要

增生性瘢痕的形成是伤口愈合常见的并发症,目前对其发病率及危险因素知之甚少。我们的目的是分析术后增生性瘢痕随时间的发病率、进展及消退情况,并确定增生性瘢痕的危险因素。本研究纳入了接受双侧乳房缩小成形术或胸骨正中切开术的患者。所有患者均在术后3个月和12个月接受检查。我们记录了术后3个月和12个月时患者的身高、体重、过敏状态、吸烟状况、皮肤类型、晒黑情况及瘢痕形状。在纳入的204例患者中,122例(60%)在术后12个月内出现增生性瘢痕。其中,117例(96%)在术后3个月内出现增生性瘢痕。术后12个月时,204例患者中有66例(32%)有增生性瘢痕。在术后3个月有增生性瘢痕的66例患者中,31例(47%)的增生性瘢痕在3个月至12个月后消退。吸烟和年龄与增生性瘢痕的形成有关。总之,60%的患者术后出现增生性瘢痕,通常在术后前三个月。三个月后仍存在的大多数增生性瘢痕在12个月后仍为增生性。年轻、不吸烟的患者更容易形成增生性瘢痕。

相似文献

1
Formation of hypertrophic scars: evolution and susceptibility.肥厚性瘢痕的形成:演变与易感性
J Plast Surg Hand Surg. 2012 Apr;46(2):95-101. doi: 10.3109/2000656X.2012.669184.
2
Perioperative conditions affect long-term hypertrophic scar formation.围手术期状况会影响长期肥厚性瘢痕的形成。
Ann Plast Surg. 2010 Sep;65(3):321-5. doi: 10.1097/SAP.0b013e3181c60f88.
3
Topical calcipotriol for preventive treatment of hypertrophic scars: a randomized, double-blind, placebo-controlled trial.外用卡泊三醇预防治疗增生性瘢痕:一项随机、双盲、安慰剂对照试验。
Arch Dermatol. 2009 Nov;145(11):1269-75. doi: 10.1001/archdermatol.2009.237.
4
Median sternotomy scar assessment.正中胸骨切开术疤痕评估。
N Z Med J. 2011 Nov 25;124(1346):57-62.
5
Minimal extracorporeal circulation (MECC) does not result in less hypertrophic scar formation as compared to conventional extracorporeal circulation (CECC) with dexamethasone.与使用地塞米松的传统体外循环(CECC)相比,微创体外循环(MECC)并不会减少肥厚性瘢痕的形成。
Perfusion. 2014 May;29(3):249-59. doi: 10.1177/0267659113511656. Epub 2013 Nov 8.
6
Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study.肥厚性瘢痕形成与表皮异常相关:一项免疫组织化学研究。
J Pathol. 1998 Oct;186(2):192-200. doi: 10.1002/(SICI)1096-9896(1998100)186:2<192::AID-PATH163>3.0.CO;2-X.
7
Time course of the angiogenic response during normotrophic and hypertrophic scar formation in humans.人正常和增生性瘢痕形成过程中的血管生成反应时间过程。
Wound Repair Regen. 2011 May-Jun;19(3):292-301. doi: 10.1111/j.1524-475X.2011.00692.x.
8
The use of silicone gel in the treatment of fresh surgical scars: a randomized study.硅凝胶在新鲜外科瘢痕治疗中的应用:一项随机研究。
Clin Exp Dermatol. 2009 Aug;34(6):688-93. doi: 10.1111/j.1365-2230.2008.03096.x. Epub 2009 Mar 14.
9
Prevalence of hypertrophic scar formation and its characteristics among the Chinese population.中国人群中肥厚性瘢痕形成的患病率及其特征
Burns. 2005 Aug;31(5):610-6. doi: 10.1016/j.burns.2005.01.022. Epub 2005 Apr 2.
10
Incidence of hypertrophic and keloid scars after N-butyl 2-cyanoacrylate tissue adhesive had been used to close parotidectomy wounds: a prospective study of 100 consecutive patients.使用2-氰基丙烯酸正丁酯组织粘合剂闭合腮腺切除术后伤口后肥厚性瘢痕和瘢痕疙瘩的发生率:对100例连续患者的前瞻性研究
Br J Oral Maxillofac Surg. 2009 Jun;47(4):290-3. doi: 10.1016/j.bjoms.2009.01.011. Epub 2009 Feb 26.

引用本文的文献

1
Scar Healing after Breast Reconstruction: A 5-year Follow-up in Asian Patients.乳房重建术后的瘢痕愈合:亚洲患者的5年随访
J Plast Reconstr Surg. 2024 Aug 23;4(1):20-25. doi: 10.53045/jprs.2024-0013. eCollection 2025 Jan 27.
2
Fractional CO Laser for Pediatric Hypertrophic Scars: Lessons Learned from a Prematurely Terminated Split-Scar Trial.用于小儿增生性瘢痕的分数二氧化碳激光:从一项提前终止的双盲对照试验中吸取的教训。
Eur Burn J. 2025 Feb 20;6(1):10. doi: 10.3390/ebj6010010.
3
Post-surgical Hypertrophic Scar in a Patient With Unilateral Temporomandibular Joint Ankylosis.
单侧颞下颌关节强直患者术后增生性瘢痕
Cureus. 2024 Aug 20;16(8):e67344. doi: 10.7759/cureus.67344. eCollection 2024 Aug.
4
Natural products for the treatment of hypertrophic scars: Preclinical and clinical studies.用于治疗增生性瘢痕的天然产物:临床前和临床研究
Heliyon. 2024 Aug 30;10(17):e37059. doi: 10.1016/j.heliyon.2024.e37059. eCollection 2024 Sep 15.
5
Scarring Skin: Mechanisms and Therapies.瘢痕皮肤:机制与治疗。
Int J Mol Sci. 2024 Jan 25;25(3):1458. doi: 10.3390/ijms25031458.
6
Efficacy of Botulinum Toxin Type A for Prevention of Post-Mastectomy Scar in Transmen: A Prospective, Randomized Study.A型肉毒毒素预防跨性别男性乳房切除术后瘢痕的疗效:一项前瞻性、随机研究。
Toxins (Basel). 2023 Oct 31;15(11):636. doi: 10.3390/toxins15110636.
7
The Efficacy of Intense Pulsed Light in the Treatment of Keloids and Hypertrophic Scars.强脉冲光治疗瘢痕疙瘩和增生性瘢痕的疗效
J Lasers Med Sci. 2023 May 6;14:e13. doi: 10.34172/jlms.2023.13. eCollection 2023.
8
Potential use of angiotensin receptor blockers in skin pathologies.血管紧张素受体阻滞剂在皮肤疾病中的潜在应用。
Iran J Basic Med Sci. 2023;26(7):732-737. doi: 10.22038/IJBMS.2023.66563.14606.
9
Development and validation of a risk assessment scale for pathological scarring.病理性瘢痕风险评估量表的制定与验证。
Int Wound J. 2023 Nov;20(9):3628-3638. doi: 10.1111/iwj.14241. Epub 2023 May 21.
10
An Updated Review of Hypertrophic Scarring.增生性瘢痕的最新综述。
Cells. 2023 Feb 21;12(5):678. doi: 10.3390/cells12050678.